Experience of Treatment at Workplace of Arterial Hypertension in Persons in Hazardous Occupations
The experience of treatment of arterial hypertension in persons in hazardous occupations at the workplace with the use of new-class antihypertensive preparations - angiotensin II receptor blocker (eprosartan) - is presented. It is shown that eprosartan monotherapy not only produced positive antihypertensive results (lower pressure and normalization of 24-hour monitoring data) but led as well to lower anxiety in patients. It is noted that the effect is most significant in the interval between 4 weeks and 6 months from the therapy begin.